Home LiteratureArticle Details
PMID: 12372345 Published · ppublish English Journal Article

Regulation of epithelial cell migration and tumor formation by beta-catenin signaling.

Experimental cell research ·Vol. 280 ·No. 1 ·2002-10-15 ·Pages 119-33

Müller T, Bain G, Wang X, Papkoff J

Abstract

Cell migration requires precise control, which is altered or lost when tumor cells become invasive and metastatic. beta-catenin plays a dual role in this process: as a member of adherens junctions it is essential to link cadherins to the cytoskeleton thereby allowing tight intercellular adhesion, and as a member of the Wnt-signaling pathway, beta-catenin is translocated into the nucleus and serves together with the LEF1/TCF-transcription factors to drive gene expression necessary for the epithelial-to-mesenchymal transition (EMT). Activated beta-catenin signaling has been implicated in the genesis of a variety of tumors. Here we demonstrate a pivotal function for beta-catenin signaling in epithelial cell migration and tumorigenesis. Hepatocyte growth factor (HGF) and epidermal growth factor (EGF) induce beta-catenin signaling under conditions where they stimulate cell motility. Ectopic expression of either stabilized beta-catenin or a regulatable form of activated beta-catenin induces cell migration in different cell types and cooperates with EGF and HGF in this process. Activation of beta-catenin signaling induces expression of the new target gene osteopontin during migration. Cells expressing stabilized beta-catenin also exhibit significantly increased capability to form tumors in a nude mouse xenograft model. The data suggest that a critical threshold of beta-catenin signaling, activated by cooperative mechanisms, may be important during the EMT and tumorigenesis.

MeSH Terms
Animals Aphidicolin/pharmacology Carcinoma/pathology Cell Line Cell Movement/physiology Cycloheximide/pharmacology Cytoskeletal Proteins/metabolism Enzyme Inhibitors/pharmacology Epidermal Growth Factor/pharmacology Epithelial Cells/physiology Gene Targeting Mice Mice, Nude Neoplasms/etiology Osteopontin Protein Synthesis Inhibitors/pharmacology Rats Sialoglycoproteins/metabolism Signal Transduction Trans-Activators/metabolism Transcriptional Activation Tumor Cells, Cultured Urinary Bladder Neoplasms/pathology beta Catenin
Chemicals
CTNNB1 protein, mouse Ctnnb1 protein, rat Cytoskeletal Proteins Enzyme Inhibitors Protein Synthesis Inhibitors Sialoglycoproteins Spp1 protein, mouse Spp1 protein, rat Trans-Activators beta Catenin Osteopontin Aphidicolin Epidermal Growth Factor Cycloheximide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Müller Thomas
Aventis Pharmaceuticals, Cambridge Genomics Center, Massachusetts 02139, USA. Mueller@Kosan.com
Bain Gerard
Wang Xin
Papkoff Jackie
Article Info
Journal
Experimental cell research
Abbr.
Exp Cell Res
ISSN
0014-4827
Published
2002-10-15
Pages
119-33
Language
English
Region
United States
NLM ID
0373226
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com